FTPP Adipotide Nasal Spray
The FTPP Adipotide Nasal Spray consists of Adipotide (FTPP), which is a synthetic chimeric peptidomimetic that has been studied in experimental research involving adipose-vasculature, and can be obtained from Direct SARMs in 15 ml and 30 ml quantities.
$100.15 – $193.88Price range: $100.15 through $193.88
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought FTPP Adipotide Nasal Spray also bought
FTPP Adipotide Nasal Spray
FTPP Adipotide is a synthetic chimeric peptidomimetic which has been studied in preclinical research focusing on the vasculature of adipose tissue and the related molecular pathways. The published research has mainly involved experimental animal models, and as a result it does not prove any clinical effects.
Direct SARMs supplies FTPP Adipotide as a pre-mixed aqueous nasal spray format for laboratory research, available in 15 ml and 30 ml sizes. The nasal spray designation describes the physical presentation of the material and does not establish intranasal bioavailability, biological activity or suitability for administration.
Documentation includes a Certificate of Analysis (COA) and HPLC purity report to provide analytical information about the supplied material and support laboratory traceability.
FTPP Adipotide Nasal Spray is supplied solely for laboratory research and is not intended for human or veterinary use.
Benefits of the nasal spray format
Visit the FTPP Adipotide Peptide Research Hub ▸
FTPP Adipotide is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy FTPP Adipotide Nasal Spray Bulgaria from Direct SARMS.
Additional information
| Size(s) | 15ml and 30ml |
| Amount Per Nasal | 15ml = 10mg | 30ml = 20mg |
| Purity | 98.2% |
| Molecular Formula | C111H206N36O28S2 |
| Molecular Weight | 2557.2 g/mol |
| Sequence | H-Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-OH |
| Physical Form | Pre-mixed aqueous solution |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this FTPP Adipotide compound?
FTPP Adipotide Nasal Spray is supplied as a pre-mixed aqueous solution for laboratory research.
Direct SARMs supplies FTPP Adipotide Nasal Spray in 15 ml and 30 ml formats.
The formulation contains Adipotide (FTPP), a synthetic chimeric peptidomimetic investigated in preclinical research involving adipose-tissue vasculature.
The nasal format is supplied as a pre-mixed liquid, whereas lyophilised Adipotide is supplied as a dry, freeze-dried research material.
No. The nasal spray designation describes the physical presentation of the research material and does not establish intranasal bioavailability, biological activity, safety or efficacy.
Certificate of Analysis
| Identity | FTPP Adipotide | CONFORMS |
| Purity (HPLC) | 98.2% | CONFORMS |
| Mass (LC-MS) | 2557.2 g/mol | CONFORMS |
| Appearance | Pre-mixed aqueous solution | CONFORMS |






